NMD4C and MDC Announce Recipients of Post-doctoral Research Fellowships

The Neuromuscular Disease Network for Canada (NMD4C) together with Muscular Dystrophy Canada (MDC) are excited to announce the recipients of a funding competition, which awarded national post-doctoral fellowships in neuromuscular research. This competition saw many incredible applicants and involved a thorough and extensive review by leading Canadian neuromuscular researchers to ensure the most promising and top-ranked researchers received the funding.

The fellowship provides salary support for early-career scientists to conduct postdoctoral studies in a laboratory focused on research of NMDs. Successful applicants will receive $40,000 in funding over a one-year period.

“This initiative will assist with training and education for the next generation of neuromuscular researchers and strengthens the biomedical infrastructure to build neuromuscular research capacity in Canada. For our clients, this means we are investing in the sustainability of neuromuscular research which brings us one step closer to finding cures.”

Stacey Lintern, CEO of Muscular Dystrophy Canada

 

“The fellowships will provide opportunities for early-career scientists to pursue exciting research in NMDs. Reducing barriers to practice in neuromuscular research is integral in allowing researchers to build a sustainable career in the field, and we are pleased to partner with Muscular Dystrophy Canada in providing these opportunities.”

Dr. Rashmi Kothary, Steering Committee Member of the NMD4C

 

Post-doctoral research fellowship recipients:

Emanuela Pannia, PhD
Research Institute, Hospital for Sick Children

Fellowship recipient Emanuela PanniaPost-doctoral Supervisor: James Dowling, MD, PhD, Clinician and Senior Scientist, The Hospital for Sick Children
Title of Research: Determining the molecular mechanisms and environmental modifiers of progressive liver disease in X-linked myotubular myopathy.
Overview: The goal of this study is to identify the cause of liver disease in X-linked myotubular myopathy (XLMTM) and the effects of diet and the immune system on its development. This study will be the first to identify causes of liver disease in XLMTM and discover new therapies to help children with this devastating disease.

 

Rebecca Robertson, PhD
McGill University

Post-doctoral Supervisor: Dr. Natasha Chang, Assistant Professor, McGill University
Title of research: The role of CARM1 in satellite cell dysfunction in Duchenne muscular dystrophy (DMD)
Overview: This project aims to fully assess issues in protein quality in DMD muscle stem cells through a variety of methods. This study will also explore how changes to CARM1 can impact the function of muscle stem cells and how they contribute to muscle repair. The ultimate goal of this work is to provide possible of treatment for DMD through these stem cells.

 

These fellows exemplify the excellence of future generations of researchers. Generous supporters of MDC made this funding competition possible. Thank you for making a difference and investing in the future of neuromuscular research.

postdocfellowship-updated

Read next...

Meet the Fellows - now live

Meet the Fellows Video Series

The NMD4C and MDC are excited to share a new videos series featuring five incredible fellows Drs. Emanuela Pannia, Rebecca Robertson, Collin Luk, Marianne Nury and Alasdair Rathbone.

Application for AFC in neuromuscular medicine approved by the Royal College

Area of Focused Competency in Neuromuscular Medicine Approved by Royal College of Physicians and Surgeons of Canada

The Neuromuscular Disease Network for Canada (NMD4C) are pleased to announce that on May 3rd, 2022, the Royal College of Physicians and Surgeons of Canada approved an application for neuromuscular medicine to be recognized as an area of focused competency (AFC) discipline. This recognition is a significant step in raising the standards of care for people affected by neuromuscular diseases in Canada.

Defeat Duchenne Canada's Clinical Trial Finder Tool

Defeat Duchenne Canada Launches New Clinical Trial Finder Tool

Defeat Duchenne Canada is proud to announce the launch of the first Clinical Trial Finder Tool for Duchenne and Becker muscular dystrophy in Canada.

KT infographic logo

Knowledge Translation Team Share Clinical Practice Guideline Infographic

The Knowledge Translation team are are glad to share an infographic of the clinical practice guideline “Promoting Sexuality and Intimate Relationships in Adults with a NMD in Occupational Therapy”

Upcoming neuromuscular conferences

Upcoming Neuromuscular Conferences in 2022

This year we are excited to anticipate the return of in-person conferences, which provide an invaluable training and networking experience to all members of the neuromuscular community and which have been dearly missed over the past two years. In 2022, Canada will host several major neuromuscular conferences, both domestic and international. Please take a moment…

Knowledge Translation Canada logo

Network’s Approach to Adapting Knowledge Translation Strategies for Neuromuscular Diseases: Knowledge Translation Canada Scientific Meeting

on behalf of the NMD4C Knowledge Translation team, Drs. Cynthia Gagnon and Homira Osman have had a poster presentation accepted for inclusion at the Knowledge Translation Canada (KT Canada) 2022 Virtual Scientific Meeting.